Lawrence Catchpole – President and CEO

Catchpole brings to Zenda Technologies over thirty years of technology industry experience as a leader and entrepreneur. He has held senior positions at M1 Global, WebTone Technologies, S1 Technologies and Dun & Bradstreet Software (formerly MSA). As Chief Strategy Officer and Founder of M1 Global, Catchpole was responsible for setting strategic business direction and technology vision while raising $15M and using innovative development techniques that returned $6 of software for every dollar invested. As Founder and CTO with WebTone, Catchpole grew WebTone into a recognized leader in multi-channel financial services sales and service market with 230 employees and $38 million in sales. WebTone was acquired by Fidelity National (NASDAQ: FNF) in September 2003. As an early employee with S1 he served as S1’s first Vice President of Services. He graduated from Georgia Institute of Technology with a B.S. in Applied Biology and a minor in electrical engineering.

Mitch Gilstrap – COO

Gilstrap brings 20+ years of senior and executive management experience to the Zenda Technologies team. Mr. Gilstrap has been responsible for business development and market launch for a variety of hi-technology based products for companies including Hitachi, Sprint, Telecorp Systems and eOn Communications. Most recently Mr. Gilstrap served as COO for eOn Communications, a global provider of VoIP systems and applications, and was responsible for company P&L, global marketing, sales, engineering, manufacturing and professional services. Under his leadership the company delivered a stock price increase of over 800% – the largest annual gain in the company’s history. Prior to joining eOn, he served as Vice President of Product Marketing at privately held Telecorp Systems, a provider of customer contact center solutions. He was responsible for product strategy and business development and helped drive the company’s exit strategy when it was acquired by Syntellect Systems. Mr. Gilstrap began his career by holding several product management and operations roles in the contact center and telecommunications industries for such companies as Sprint and Hitachi. Mr. Gilstrap holds a Bachelor’s degree in Engineering from the Georgia Institute of Technology.

Ron Scalf - VP Sales and Marketing

Scalf brings over 20 years of health care industry sales and marketing experience to the Zenda team.  He has played key roles in several product launch initiatives and has demonstrated success in the design and execution of strategic marketing plans, building and managing sales teams and channel distribution networks and successful sales strategies targeting primary care providers.  Prior to joining Zenda, Mr. Scalf held executive sales and marketing roles for companies including Sciele Pharma, Inventive Health and Solvay Pharmaceuticals.  Mr. Scalf holds a marketing and management degree from East Tennessee State University.

Management Advisory Board

John Baumstark, Chairman and CEO – Suniva

Prior to Suniva, John was an Operating Partner at H.I.G. Ventures, where he played an active role in the overall strategy of the fund as well as the development of portfolio companies.  John has over 20 years of technology experience in early and late-stage private and public companies. Most recently, he was responsible for overseeing global operations of IBM’s WebSphere Customer Center unit, part of IBM’s newly formed Enterprise Master Data Solutions group within the IBM Software Group.

Prior to IBM, John was president and CEO of DWL, the leader in Customer Data Integration software. Under John’s leadership the company was cashflow positive for 20 consecutive quarters, was profitable and was named one of the fastest growing technology companies in North America three years in a row by Deloitte and Touche. DWL was acquired by IBM in 2005.  Prior to DWL, John served as the Chief Operating Officer of TRADEX Technologies. Under John’s leadership, TRADEX became the market leader in digital marketplace platforms. In March of 2000, TRADEX was acquired by Ariba for $5.6 billion, making it one of the largest software acquisitions in history.

Before TRADEX, John directed worldwide field operations for Infinium Software. There he built over $100 million in revenue, led a successful initial public offering and acquired two companies. Before joining Infinium, Baumstark held sales and sales management positions with Management Science America (MSA), a mainframe application software provider.  John graduated from Colorado College with a BA in Business / Economics. He currently serves on the Board of Directors of Procuri, Inc., an on demand software as a service company.

Thomas S. Stribling

Mr. Stribling has more than 30 years experience in the health care and pharmaceutical industries.  Currently he is President and CEO of Northampton, LLC, a company that he co-founded to license and develop unique compounds targeted to the gastrointestinal market.  Until its successful sale, Mr. Stribling served as President and CEO of Therics, Inc, a Princeton, NJ based tissue engineering company developing products based upon intellectual property licensed from MIT.  Before Therics, he started three other companies; one a pharmaceutical division of a major corporation; a second at the request of a leading venture capital firm and another that he conceived, privately funded, grew and then sold to a major foreign corportation in less than four years.

Previous senior corporate responsibilities included President, UCB Pharma, and Group Vice President, Solvay Pharmaceuticals.  He was Founder, Chairman and President of Northampton Medical, a company specializing in female health care products and also Vice President of Whitby, Inc., the pharmaceutical division of Ethyl Corporation.  He also served as President and CEO of Scandipharm, Inc. and DermaCo, Inc.  Mr. Stribling spent several years as Chairman of the Board of Advisory Directors at Legacy Securities Corporation, an Atlanta and Memphis-based investment-banking group. 

Mr. Stribling is a member of the Board of Directors of Matria Healthcare, Inc. (MATR, NASDAQ), an Atlanta-based public corporation that is a leading provider of comprehensive disease management services to health plans and employers.  In late 2007, he joined the Board of Directors of Intelliject, LLC, a privately held company that is developing unique drug delivery technologies.  Beginning April 2000, Mr. Stribling became a member of the Dean’s Advisory Committee at the University of Alabama School of Medicine.  He holds a BA Business from the University of Alabama and is graduate of the Stanford University Executive Program. 

Mark L. Braunstein, MD

Dr. Braunstein is Senior Adviser for health information technology to Focus, LLC, an investment banking firm which provides a range of services tailored to the needs of emerging growth and middle market businesses.  Previously he was co-founder, Chairman and CEO of Patient Care Technologies,Inc (PtCT)., a 1998 Inc 500 company, and a leading provider of electronic patient record and care management systems to the home care industry. PtCT was acquired by MEDITECH in 2007.

He received his BS degree from MIT in 1969 and his MD degree from the Medical University of South Carolina (MUSC) in 1974. After an internship at Washington University he joined the faculties of Medicine and Pharmacy at MUSC until he left in 1978 to co-found PROHECA, an early developer of

clinical pharmacy systems. PROHECA was acquired by National Data Corporation (NDC) in 1981 and was the seed for what is now NDCHealth. At NDC he ran what was then the NDC Healthcare Division for five years and was the company’s President and COO for three years until he left in 1990 to co-found PtCT.

He is the author of over fifty papers; articles and book chapters devoted to various aspects of clinical automation.  He is the immediate past Chairman of the Board of the Georgia Advanced Technology Ventures (GATV) – a corporation that supports the Advanced Technology Development Center, a technology incubator operated by the Georgia Institute of Technology.  He is also a past Chairman of the American-Israel Chamber of Commerce, Southeast Region and of the Atlanta Chapter of the MIT Enterprise Forum.  He won a 1996 Entrepreneur of the Year Award for the Southeast Region, received a 1995 Innovation in Medical Management Award from the American Society of Physician Executives and received the 2006 Founder’s Award from the American-Israel Chamber of Commerce, Southeast Region.

Science Advisory Board

Michelle La Placa, PhD

Associate Professor, Department of Biomedical Engineering at Georgia Tech and Emory University. Dr. LaPlaca is a member of the Laboratory for Neuroengineering at Georgia Tech, the Georgia Tech / Emory Center for the Engineering of Living Tissue, the Neuroscience Program at Emory, and the Southern Consortium for Injury Biomechanics at the University of Alabama Birmingham. She has received an NSF CAREER award and has active research projects funded by both NIH and foundations. Visit her Laboratory for Neuroengineering website.

David Wright, MD

Assistant Professor, Director of Research, Department of Emergency Medicine, Emory University School of Medicine. Dr. Wright is Assistant Professor in the Department of Emergency Medicine and the Co-Director of the Emergency Medicine Research Center at Emory University. He is a board certified Emergency Medicine Physician, practicing at both Emory University Hospital and Grady Memorial Hospital. He is program faculty for the Graduate School’s Department of Behavioral and Biological Sciences at Emory University, core faculty for the Center for Injury Control and Prevention at Emory University, and program faculty for the Department of Biomedical Engineering at Georgia Tech and Emory University. See more Emory Emergency Medicine